Targeting autophagy during cancer therapy to improve clinical outcomes - PubMed (original) (raw)

Review

Targeting autophagy during cancer therapy to improve clinical outcomes

Jean M Mulcahy Levy et al. Pharmacol Ther. 2011 Jul.

Abstract

Autophagy is a catabolic process that turns over long-lived proteins and organelles and contributes to cell and organism survival in times of stress. Current cancer therapies including chemotherapy and radiation are known to induce autophagy within tumor cells. This is therefore an attractive process to target during cancer therapy as there are safe, clinically available drugs known to both inhibit and stimulate autophagy. However, there are conflicting positive and negative effects of autophagy and no current consensus on how to manipulate autophagy to improve clinical outcomes. Careful and rigorous evaluation of autophagy with a focus on how to translate laboratory findings into relevant clinical therapies remains an important aspect of improving clinical outcomes in patients with malignant disease.

PubMed Disclaimer

Figures

Fig. 1

Cited by

Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells.
Del Bello B, Toscano M, Moretti D, Maellaro E. Del Bello B, et al. PLoS One. 2013;8(2):e57236. doi: 10.1371/journal.pone.0057236. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437349 Free PMC article.
Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer.
Fu X, Tan T, Liu P. Fu X, et al. Cancer Manag Res. 2020 Jun 16;12:4595-4604. doi: 10.2147/CMAR.S253345. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606952 Free PMC article. Review.
Autophagy, Oxidative Stress and Cancer Development.
Taucher E, Mykoliuk I, Fediuk M, Smolle-Juettner FM. Taucher E, et al. Cancers (Basel). 2022 Mar 23;14(7):1637. doi: 10.3390/cancers14071637. Cancers (Basel). 2022. PMID: 35406408 Free PMC article. Review.
Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy.
Xu J, Patel NH, Saleh T, Cudjoe EK Jr, Alotaibi M, Wu Y, Lima S, Hawkridge AM, Gewirtz DA. Xu J, et al. Radiat Res. 2018 Nov;190(5):538-557. doi: 10.1667/RR15099.1. Epub 2018 Aug 22. Radiat Res. 2018. PMID: 30132722 Free PMC article.
Autophagy and cancer therapy.
Thorburn A, Thamm DH, Gustafson DL. Thorburn A, et al. Mol Pharmacol. 2014 Jun;85(6):830-8. doi: 10.1124/mol.114.091850. Epub 2014 Feb 26. Mol Pharmacol. 2014. PMID: 24574520 Free PMC article. Review.

References

1. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007;117(2):326–336. - PMC - PubMed
1. Anandappa G, Hollingdale A, Eisen T. Everolimus - a new approach in the treatment of renal cell carcinoma. Cancer Manag Res. 2010;2:61–70. - PMC - PubMed
1. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol. 2007;72(1):29–39. - PubMed
1. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008;68(5):1485–1494. - PubMed
1. Barth S, Glick D, Macleod KF. Autophagy: assays and artifacts. J Pathol. 2010;221(2):117–124. - PMC - PubMed

Targeting autophagy during cancer therapy to improve clinical outcomes - PubMed (original) (raw)